G1 Therapeutics Inc (STU:G1H)
€ 6.39 0 (0%) Market Cap: 339.15 Mil Enterprise Value: 327.68 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 32/100

Q4 2020 G1 Therapeutics Inc Earnings Call Transcript

Feb 24, 2021 / 09:30PM GMT
Release Date Price: €20.55 (+0.74%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the G1 Therapeutics Fourth Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker host today, Will Roberts, Head of Investor actions at G1 Therapeutics. Please go ahead.

William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Olivia. Good afternoon, everybody, and welcome to the G1 conference call to discuss our fourth quarter and full year 2020 financial results and business update. The press release on these financial results was issued after market close this afternoon and can be found in our news section of our corporate website, g1therapeutics.com.

On this afternoon's call, the team will provide an overview of the fourth quarter and full year 2020, including an update on our launch progress with COSELA, which was approved by the U.S. Food and Drug Administration on February 12,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot